Skip to content
Varieties from the European CatalogueGrown in FranceSlow dryingDispatched within 24 working hours — before noonEU delivery — 24-72 hRight of withdrawal — 14 daysCertificate available — per batch
Canna·wikiJWH-193

ECS modulator (research)

Narcotic: generic clause

JWH-193

(4-méthylnaphtalén-1-yl)-[1-(2-morpholin-4-yléthyl)indol-3-yl]méthanone

Aliases.JWH-193 · 4-méthylnaphtoyl-JWH-200

A synthetic naphthoylindole, a highly affine CB1 agonist; classified as a narcotic in France by generic clause.

Updated on

Level of detail

Harm-reduction warning

No characterised human dose: animal / in vitro data only. Effect profile, safety margin and acute toxicity are not documented in human clinical practice. Extremely potent compound: severe effects, seizures and deaths reported in the literature.

Identifiers

Formula
C₂₆H₂₆N₂O₂
Molar mass
398.50 g·mol⁻¹
CAS
133438-58-1
PubChem CID
10250276
Origin
A wholly synthetic compound. It has no natural occurrence, is found in no plant and is not a product of metabolism. Its production belongs to the laboratory, for pharmacological research purposes, and to clandestine manufacture intended for the synthetic cannabinoid market.
InChIKey
ICKWPPYMDARCKJ-UHFFFAOYSA-N

In plain terms

JWH-193 is a synthetic cannabinoid, with no botanical relation to hemp. It binds very strongly to the CB1 receptor, far more than THC. No human study exists, no dose is known, and it is classified as a narcotic in France.

Receptors and activity

  • CB1
    Affinité rapportée de l'ordre de 6 nM (Huffman et Padgett 2005)Agonist
  • CB2
    Affinité non déterminée pour ce composé précisAgonist
  • Agonist
  • Partial agonist
  • Antagonist
  • Modulator
  • Inverse agonist

Hover over a row for the precise value (Ki, EC50…)

Subjective signature

Hover over an axis to read its definition.

  • Calm
    20
  • Clarity
    5
  • Sleep
    30
  • Appetite
    40
  • High
    60

Editorial estimate, not clinical.

Pharmacology

JWH-193 belongs to the naphthoylindole family, those synthetic cannabinoids built on an indole core linked by a ketone to a naphthalene, whose leader JWH-018 opened the market in products sold under the misleading label of incense or smoking mixtures. It is distinguished by its morpholinoethyl chain borne by the indole nitrogen, inherited from JWH-200, and by a methyl at position 4 of the naphthalene. That last modification is the compound's reason for existing within the series: it multiplies by about seven the affinity for the CB1 receptor, which stands around 6 nanomolar, far above that of Δ9-THC. The structure-activity relationship work of Huffman and his team, covering dozens of analogues, served precisely to map the effect of naphthalene substituents and of N-alkyl chain length on CB1 affinity and on CB2 selectivity, and to identify along the way several highly selective CB2 agonists. What this entry cannot say must be stressed. No specific functional efficacy study, no pharmacokinetic, metabolic or human toxicology data are published for this compound. The risks documented for the whole class of synthetic CB1 agonists, most of which are full agonists where THC is only a partial agonist, cannot be quantified for it in particular, but they apply by construction: agitation, tachycardia, convulsions and acute psychiatric disturbances have been reported for this entire family.

Origin (research tool)

An entirely chemical route, described here by class only. The molecule combines three elements assembled by synthesis: an indole core, a ketone function linking position 3 of that indole to a methylated naphthalene, and a morpholinoethyl chain borne by the indole nitrogen. It does not exist in nature and proceeds from no enzymatic route.

Structural classification

Class
ECS modulator (research)
Origin
A wholly synthetic compound. It has no natural occurrence, is found in no plant and is not a product of metabolism. Its production belongs to the laboratory, for pharmacological research purposes, and to clandestine manufacture intended for the synthetic cannabinoid market.
Status
Narcotic: generic clause

References

  1. 1.Huffman et Padgett 2005 : développements récents en chimie médicinale des indoles, pyrroles et indènes cannabimimétiquesPMID 15974991
  2. 2.Huffman et coll. 2005 : relations structure-activité des 1-alkyl-3-(1-naphtoyl)indoles sur les récepteurs CB1 et CB2PMID 15582455

Structured data

InChIKey
ICKWPPYMDARCKJ-UHFFFAOYSA-N
SMILES
CC1=CC=C(C2=CC=CC=C12)C(=O)C3=CN(C4=CC=CC=C43)CCN5CCOCC5
Formula
C26H26N2O2
Molar mass
398.50 g·mol⁻¹
CAS
133438-58-1
PubChem CID
10250276
Machine-readable entry (JSON)

LLM ingestion format: a structured superset of the entry (identifiers, binding, versioned legal status). Full corpus.